Alzheimer's Fast Track 2024
More than 60 scientists from all career stages gathered to discuss critical topics in the field of Alzheimer’s disease research at BrightFocus Foundation’s 16th annual Alzheimer’s Fast Track, held Oct. 2-4 in Chicago, IL.
About Alzheimer’s Fast Track
Learn from experts in the field of Alzheimer’s disease and related dementias at the Alzheimer’s Fast Track workshop. Designed for graduate students, postdoctoral fellows, and other early-career scientists focused on Alzheimer’s disease research, this immersive learning experience will accelerate your knowledge, expertise, and visibility in this exciting field.
2024 Event Details
October 2-4, 2024
Chicago, Illinois
Official pre-meeting to Society for Neuroscience
Contact researchgrants@brightfocus.org with questions.
What Attendees Are Saying
I cannot believe how much this BrightFocus Fast Track has shaped my knowledge, my career and me personally. I also made friends forever. Not only I am so much more prepared and more confident to write grants but also I gained skills to communicate and to share my science. This workshop is the greatest idea to help students build their careers more successfully. Every scientist should go through a workshop like this one. Thank you for the opportunity!
Amira Latif-Hernandez, PhD, Alzheimer’s Disease Research Grant Recipient and Fast Track Attendee
The BrightFocus team shows genuine care for their fellows and their individual career paths, which was evident during the Fast Track event. The opportunity to easily connect with mentors and receive personalized advice truly stood out.
Julie Ottoy, PhD, Alzheimer’s Disease Research Grant Recipient and Fast Track Attendee
Co-Chairs
Frank LaFerla, PhD
University of California, Irvine
Cynthia Lemere, PhD
Brigham and Women’s Hospital, Harvard Medical School
Sharyn Rossi, PhD
BrightFocus Foundation
Harry Steinbusch, PhD
Maastricht University,
The Netherlands
Related News & Research Breakthroughs
Press Release
BrightFocus Foundation and Dementia Alliance North Carolina Partner to Advance Alzheimer’s Innovation
The partnership supports an outstanding researcher at UNC Chapel Hill who is advancing novel gene therapy strategies for Alzheimer’s disease.
Article
The Early Alzheimer’s Signals We’ve Been Missing (Until Now)
Using advanced genetic sequencing, BrightFocus Alzheimer’s Disease Research-funded scientist Dr. Mark Ebbert is identifying overlooked changes in the brain that could finally unlock a way to diagnose Alzheimer’s before it begins.
Article
New Blood Test Could Personalize Alzheimer’s Treatment Like Never Before
A new Alzheimer’s blood test may reveal how far the disease has progressed and identify who’s most likely to benefit from anti-amyloid therapies.
Article
What Early-Life Brain Activity May Reveal About Alzheimer’s Risk
BrightFocus Alzheimer’s Disease Research grant recipient Keith Hengen, PhD, is pioneering a novel approach to identifying Alzheimer’s risk in early life, which could enable earlier diagnosis, risk reduction, and treatment.
Article
FDA Clears First Blood Test to Aid in Alzheimer’s Diagnosis
The Lumipulse G β-Amyloid Ratio (1-42/1-40) blood test, manufactured by Fujirebio Diagnostics, measures two forms of amyloid-beta in the blood.
Article
Does Disrupting the Brain’s Clock Influence Alzheimer’s?
An Alzheimer’s Disease Research-funded researcher is investigating the link between circadian rhythm disruption by jet lag and Alzheimer’s in the hopes of finding new treatment targets.